RT: For Decision Makers in Respiratory Care
  • Disorders & Diseases
    • Chronic Pulmonary Disorders
    • Infectious Diseases
    • Critical Care
    • Cardiopulmonary & Thoracic
    • Sleep Medicine
  • Public Health
    • Smoking
    • Healthcare & Policy
    • Pediatrics
  • Products & Treatment
    • Monitoring & Treatment
    • Diagnostics & Testing
    • Pharmaceuticals
    • Industry & Regulatory News
  • Department Management
    • Clinical
    • Education
    • Conferences & CEU
  • Edition Archive

Select Page

Tag: Bayer

All

Latest
FDA Approves Bayer’s Over the Counter Nasal Allergy Spray

FDA Approves Bayer’s Over the Counter Nasal Allergy Spray

The FDA removed the prescription requirement for Bayer’s Asteprofor seasonal and year-round allergic rhinitis nasal spray.

  • FDA Approves Astepro Antihistamine for OTC Use

  • Bayer Enrolling Patients in Phase 4 PAH Trial of Riociguat

  • Bayer to Present Data on PAH Drugs at ATS 2017

  • EMA Halts Use of Riociguat for PH Associated Idiopathic Interstitial Pneumonia

  • Riociguat Safe, Effective for Treating CTEPH Long-term

  • Bayer Terminates Phase II Study of Riociguat for PH-associated Idiopathic Interstitial Pneumonias

  • Bayer’s Investigational Drug Shows Promise in PAH Treatment, Phase III Study Finds

All

Latest
Sorry, No Posts Found

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found

Resources

  • Edition Archive
  • Featured Reports
  • Podcasts
  • White Papers
  • Webinars
  • Videos

Helpful Links

  • Marketing Solutions
  • Subscribe
  • Contact Us

Designed by Elegant Themes | Powered by WordPress

  • Privacy Policy
  • Terms of Service
  • Copyright